Organon BioSciences
1923
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
2
FINANCING ROUNDS
2
INVESTMENTS
Description
Manufacturer of pharmaceutical products. The company develops, manufactures and markets products targeting selected therapeutic areas in human pharmaceuticals and covering a wide range of species in animal health. It offers its products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care and neuroscience, immunology, animal health and oncology.
Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- Molenstraat 110
- 5342 CC Oss
- Netherlands
Organon BioSciences Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Organon BioSciences‘s full profile, request access.
Request full access to PitchBookOrganon BioSciences Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 & 0000000 | 22-May-2013 | 000000000 00000 00 | Medical Supplies | ||
| Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) | 26-Jun-2007 | Corporate Asset Purchase | Pharmaceuticals | 00000000 0000000000 |
Organon BioSciences Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Organon BioSciences‘s full profile, request access.
Request full access to PitchBook